Please login to the form below

Not currently logged in

Roche nominates Dr Claudia Süssmuth Dyckerhoff to board

She is set to replace Professor Dr Beatrice Weder di Mauro

Roche - Basel, SwitzerlandRoche's board of directors have lined up Dr Claudia Süssmuth Dyckerhoff to replace Professor Dr Beatrice Weder di Mauro, who has decided to not stand for re-election at the company's annual general meeting in March.

Weder di Mauro has been a member of the board since 2006 and also served on its audit committee.

Dyckerhoff is currently senior partner at McKinsey & Company and sector leader Asia health services and systems.

Christoph Franz, chairman of Roche, said: “As a member of the board and the audit committee, Beatrice Weder di Mauro has made significant contributions to Roche's success with her broad expertise in economics.”

He added: “I am delighted with our nomination of Claudia Süssmuth Dyckerhoff for election as a new member of the board. She is a leader with extensive international experience in strategic consultancy in the healthcare industry, especially in Asian growth markets.”

7th January 2016

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

When is it time to rebrand?
The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....